{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","id":"ImmDS-2013-0201","parameter":[{"name":"assessentDate","valueDate":"2020-06-29"},{"name":"patient","resource":{"resourceType":"Patient","id":"2013-0201","name":[{"text":"Dose 1 to dose 2 interval 28 days\nEvaluation_Test_Type: Interval: At Minimum\nGeneral_Description: This test case desribes when dose #2 of the Hep B vaccine is administered at an interval of 28 days after dose #1 that the dose is considered to be valid."}],"gender":"female","birthDate":"2020-06-01"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0201-dose1","status":"completed","date":"2020-06-01T00:00:00.000","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"8","display":"RECOMBIVAX-PEDS"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"RECOMBIVAX-PEDS"}]},"patient":{"reference":"Patient/2013-0201"},"wasNotGiven":false,"reported":false}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0201-dose2","status":"completed","date":"2020-06-29T00:00:00.000","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"8","display":"RECOMBIVAX-PEDS"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"RECOMBIVAX-PEDS"}]},"patient":{"reference":"Patient/2013-0201"},"wasNotGiven":false,"reported":false}}]},"request":{"method":"PUT","url":"Parameters"}}]}